Literature DB >> 27131223

Pretreatment computed tomographic gross tumor volume as predictor of persistence of tracheostomy and percutaneous endoscopic gastrostomy tube in patients undergoing larynx preservation.

Newton J Hurst1, Lucio M Pereira2, Michael M Dominello3, Gregory Dyson4, Pamela Laszewski3, Natasha Robinette5, Ho-Sheng Lin2, George Yoo2, Ammar Sukari4, Harold Kim3.   

Abstract

BACKGROUND: Although larynx preservation affords patients improvements in laryngectomy-free survival, little has been reported regarding the functional outcomes after larynx preservation. The purpose of this study was to report the predictive value of pretreatment CT-gross tumor volume (GTV) for persistence of tracheostomy and percutaneous endoscopic gastrostomy (PEG) tube in larynx preservation patients.
METHODS: Each patient had a CT scan before initiation of therapy and the GTV was contoured.
RESULTS: Using recursive partitioning analysis (RPA), threshold GTVs of 27.16 cc and 12 cc were identified for association of time with tracheostomy and PEG tube, respectively. Median (95% confidence interval [CI]) times above and below these thresholds were 1.84 (1.06-not reached [NR]) and 0.75 (0.63-1.26) years, respectively (p = .03) for time with tracheostomy and 1.75 (1.34-NR) and 0.84 (0.46-NR) years, respectively (p = 0.10) for time with PEG tube.
CONCLUSION: This study demonstrates that pretreatment CT-GTV is predictive of an approximately 2.5-fold and approximately 2-fold, respectively, increase in time with tracheostomy and PEG tube.
© 2016 Wiley Periodicals, Inc. Head Neck 38: First-1458, 2016. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  functional outcomes; laryngeal cancer; larynx preservation; prognosis quality of life

Mesh:

Year:  2016        PMID: 27131223      PMCID: PMC6857528          DOI: 10.1002/hed.24458

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  13 in total

1.  Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.

Authors:  Arlene A Forastiere; Helmuth Goepfert; Moshe Maor; Thomas F Pajak; Randal Weber; William Morrison; Bonnie Glisson; Andy Trotti; John A Ridge; Clifford Chao; Glen Peters; Ding-Jen Lee; Andrea Leaf; John Ensley; Jay Cooper
Journal:  N Engl J Med       Date:  2003-11-27       Impact factor: 91.245

2.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Authors:  Gregory T Wolf; Susan Gross Fisher; Waun Ki Hong; Robert Hillman; Monica Spaulding; George E Laramore; James W Endicott; Kenneth McClatchey; William G Henderson
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

3.  Epidermoid carcinoma of the supraglottic larynx. Role of neck dissection in initial surgical treatment.

Authors:  J P Shah; H R Tollefsen
Journal:  Am J Surg       Date:  1974-10       Impact factor: 2.565

4.  The quality of life of patients following treatment for laryngeal cancer.

Authors:  A R Harwood; E Rawlinson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-03       Impact factor: 7.038

5.  Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group.

Authors:  J E Terrell; S G Fisher; G T Wolf
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-09

6.  Factors predictive of poor functional outcome after chemoradiation for advanced laryngeal cancer.

Authors:  Jonathan Staton; K Thomas Robbins; Lisa Newman; Sandeep Samant; Merry Sebelik; Francisco Vieira
Journal:  Otolaryngol Head Neck Surg       Date:  2002-07       Impact factor: 3.497

7.  The evaluation of treatment of patients with extensive squamous cancer of the vocal cords.

Authors:  R H Jesse
Journal:  Laryngoscope       Date:  1975-09       Impact factor: 3.325

Review 8.  Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review.

Authors:  Lisette van der Molen; Maya A van Rossum; Lori M Burkhead; Ludi E Smeele; Frans J M Hilgers
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-30       Impact factor: 2.503

9.  Clinical predictors of quality of life in patients with head and neck cancer.

Authors:  Jeffrey E Terrell; David L Ronis; Karen E Fowler; Carol R Bradford; Douglas B Chepeha; Mark E Prince; Theodoros N Teknos; Gregory T Wolf; Sonia A Duffy
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-04

10.  Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer.

Authors:  Arlene A Forastiere; Qiang Zhang; Randal S Weber; Moshe H Maor; Helmuth Goepfert; Thomas F Pajak; William Morrison; Bonnie Glisson; Andy Trotti; John A Ridge; Wade Thorstad; Henry Wagner; John F Ensley; Jay S Cooper
Journal:  J Clin Oncol       Date:  2012-11-26       Impact factor: 44.544

View more
  3 in total

1.  Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer.

Authors:  Mona Kamal; Sweet Ping Ng; Salman A Eraj; Crosby D Rock; Brian Pham; Jay A Messer; Adam S Garden; William H Morrison; Jack Phan; Steven J Frank; Adel K El-Naggar; Jason M Johnson; Lawrence E Ginsberg; Renata Ferrarotto; Jan S Lewin; Katherine A Hutcheson; Carlos E Cardenas; Mark E Zafereo; Stephen Y Lai; Amy C Hessel; Randal S Weber; G Brandon Gunn; Clifton D Fuller; Abdallah S R Mohamed; David I Rosenthal
Journal:  Oral Oncol       Date:  2018-02-10       Impact factor: 5.337

2.  Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx.

Authors:  Jay C Shiao; Abdallah S R Mohamed; Jay A Messer; Katherine A Hutcheson; Jason M Johnson; Heiko Enderling; Mona Kamal; Benjamin W Warren; Brian Pham; William H Morrison; Mark E Zafereo; Amy C Hessel; Stephen Y Lai; Merril S Kies; Renata Ferrarotto; Adam S Garden; Donald F Schomer; G Brandon Gunn; Jack Phan; Steven J Frank; Beth M Beadle; Randal S Weber; Jan S Lewin; David I Rosenthal; Clifton D Fuller
Journal:  Head Neck       Date:  2017-05-02       Impact factor: 3.147

3.  App-Controlled Treatment Monitoring and Support for Head and Neck Cancer Patients (APCOT): Protocol for a Prospective Randomized Controlled Trial.

Authors:  Tanja Sprave; Daniela Zöller; Raluca Stoian; Alexander Rühle; Tobias Kalckreuth; Erik Haehl; Harald Fahrner; Harald Binder; Anca-Ligia Grosu; Felix Heinemann; Nils Henrik Nicolay
Journal:  JMIR Res Protoc       Date:  2020-12-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.